How cannabis retailers can avoid problems storing concentrates
Featured

How cannabis retailers can avoid problems storing concentrates

 By Patrick Maravelias • July 1, 2022

Sponsored Content

MOST POPULAR THIS MONTH

Cannabis retailers increasingly discounting their products
Inaccurate strain names, poor labeling hinder marijuana industry, study shows
Opinion: How cannabis retailers can improve woefully inadequate consumer education
FDA takes another look at CBD, but insiders are skeptical much will change
As New York develops adult-use marijuana rules, equity concerns emerge
Mjbizdaily logo

Your Cannabis Business Year Starts Here — Lowest Prices of the Year

Las Vegas
November 15-18, 2022
REGISTER NOW

Latest

MJBizDaily to resume publishing Tuesday
July 1, 2022
Key marijuana banking ally continues fight to get SAFE across finish line
July 1, 2022
‘Big Bang Theory’ actor wins court assistance to fight CBD scam
July 1, 2022
Massachusetts marijuana retailer must repay employees $33,000 in tips
July 1, 2022
California governor signs tax relief for cannabis businesses into law
July 1, 2022
Colorado marijuana testing lab’s potency certification is suspended
July 1, 2022
See More

Canada

featured-image

Still no timeline for launch of Canada's overdue Cannabis Act review

By Solomon Israel

featured-image

What corporate earnings say about your marijuana business

By Andy Obermueller

featured-image

Health Canada: No new marijuana beverage rules before fall 2022

By Matt Lamers

featured-image

'We're starting slow': Q&A with Boston Beer cannabis chief Paul Weaver

By Matt Lamers

Cultivation

featured-image

CT Pharma uses FDA approval to provide cannabis for Yale University research studies

By Omar Sacirbey

featured-image

Will a looming recession sink the cannabis industry, or will it stay afloat?

By Bart Schaneman

featured-image

Opinion: How marijuana companies can protect themselves in a cash-based world

By Naomi Granger

featured-image

Adult-use marijuana companies struggle to stay afloat amid overproduction, falling prices

By Patrick Maravelias

Manufacturing

featured-image

Papa & Barkley leans on customer database to research marijuana product efficacy

By Omar Sacirbey

featured-image

Will a looming recession sink the cannabis industry, or will it stay afloat?

By Bart Schaneman

featured-image

Still no timeline for launch of Canada's overdue Cannabis Act review

By Solomon Israel

featured-image

Opinion: How marijuana companies can protect themselves in a cash-based world

By Naomi Granger

Retail

featured-image

How cannabis retailers can avoid problems storing concentrates

By Patrick Maravelias

featured-image

Finger-pointing in Arizona over marijuana social equity hurdles

By John Schroyer

featured-image

Key marijuana tax reforms absent in California budget blueprint

By Chris Casacchia

featured-image

Opinion: How marijuana companies can protect themselves in a cash-based world

By Naomi Granger

Legalization

featured-image

Still no timeline for launch of Canada's overdue Cannabis Act review

By Solomon Israel

featured-image

Finger-pointing in Arizona over marijuana social equity hurdles

By John Schroyer

featured-image

Rhode Island, Mississippi, Maryland lead 2022 marijuana legalization via legislatures

By Jeff Smith

featured-image

Key marijuana tax reforms absent in California budget blueprint

By Chris Casacchia

Finance

featured-image

Know your cannabis business' overhead ratio

By MJBizDaily Staff

featured-image

Opinion: How marijuana companies can protect themselves in a cash-based world

By Naomi Granger

featured-image

What corporate earnings say about your marijuana business

By Andy Obermueller

featured-image

How a recession might impact the cannabis industry

By Andy Obermueller

Science

featured-image

Marijuana companies find increasing acceptance for therapeutic MJ research

By Omar Sacirbey

featured-image

Vireo partners with medical school to conduct pioneering cannabis research at a low cost

By Omar Sacirbey

featured-image

DEA licenses open new doors for marijuana-based therapeutic research

By Omar Sacirbey

featured-image

CT Pharma uses FDA approval to provide cannabis for Yale University research studies

By Omar Sacirbey